Lifestyle Modification in Secondary Prevention: Beyond Pharmacotherapy
- PMID: 30202327
- PMCID: PMC6125029
- DOI: 10.1177/1559827616651402
Lifestyle Modification in Secondary Prevention: Beyond Pharmacotherapy
Abstract
Despite significant advances in medical technology and pharmacology, cardiovascular disease (CVD) remains a major contributor to health care expenses and the leading cause of death in the United States. Patients with established CVD and their health care providers are challenged with achieving cardiovascular risk reduction to decrease the likelihood of recurrent cardiovascular events. This "secondary prevention" can be achieved, in part, through adherence to prescribed pharmacotherapies that favorably modify major coronary risk factors (ie, hypertension, hypercholesterolemia, diabetes, and obesity). However, lifestyle modification can also be helpful in this regard, providing independent and additive benefits to the associated reductions in cardiovascular morbidity and mortality. Accordingly, physicians and other health care providers should routinely counsel their coronary patients to engage in structured exercise and increased lifestyle physical activity, consume a heart-healthy diet, quit smoking and avoid secondhand smoke, and purposefully address psychosocial stressors that may elevate cardiovascular risk. These lifestyle interventions, either as an adjunct to medication therapy or independently in those patients where medications may be poorly tolerated, cost prohibitive, or ineffective, can significantly decrease cardiovascular mortality and the risk of recurrent cardiac events.
Keywords: cardiovascular mortality; lifestyle modification; risk factor reduction; secondary prevention.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




Similar articles
-
Heartfelt living: Deciphering the link between lifestyle choices and cardiovascular vitality.Curr Probl Cardiol. 2024 Mar;49(3):102397. doi: 10.1016/j.cpcardiol.2024.102397. Epub 2024 Jan 15. Curr Probl Cardiol. 2024. PMID: 38232921 Review.
-
Managing tobacco use: the neglected cardiovascular disease risk factor.Eur Heart J. 2013 Nov;34(42):3259-67. doi: 10.1093/eurheartj/eht352. Epub 2013 Sep 7. Eur Heart J. 2013. PMID: 24014389 Review.
-
[Cardiovascular risk factors and prevention in women: similarities and differences].Ital Heart J Suppl. 2001 Feb;2(2):125-41. Ital Heart J Suppl. 2001. PMID: 11255880 Review. Italian.
-
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.Eur Heart J. 2014 Feb;35(6):353-64. doi: 10.1093/eurheartj/eht407. Epub 2013 Nov 27. Eur Heart J. 2014. PMID: 24288261 Review.
-
Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.Curr Vasc Pharmacol. 2019;17(4):401-410. doi: 10.2174/1570161116666180608121720. Curr Vasc Pharmacol. 2019. PMID: 29886832
Cited by
-
The effect of barberry (Berberis integerrima) on lipid profile and systemic inflammation in subjects with cardiovascular risk factors: a randomized controlled trial.BMC Complement Med Ther. 2022 Mar 7;22(1):59. doi: 10.1186/s12906-022-03539-8. BMC Complement Med Ther. 2022. PMID: 35255880 Free PMC article. Clinical Trial.
-
Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.Polymers (Basel). 2023 Jul 1;15(13):2928. doi: 10.3390/polym15132928. Polymers (Basel). 2023. PMID: 37447573 Free PMC article. Review.
-
Approaching Sarcopenic Obesity in Young and Middle-Aged Female Adults in Weight Management Settings: A Narrative Review.Healthcare (Basel). 2022 Oct 15;10(10):2042. doi: 10.3390/healthcare10102042. Healthcare (Basel). 2022. PMID: 36292489 Free PMC article. Review.
-
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research.Indian Heart J. 2022 Sep-Oct;74(5):341-350. doi: 10.1016/j.ihj.2022.07.009. Epub 2022 Aug 5. Indian Heart J. 2022. PMID: 35940234 Free PMC article. Review.
-
Assessing Associations of Nurse-Managed Hypertension Care on Pharmacotherapy, Lifestyle Counseling, and Prevalence of Comorbid Cardiometabolic Diseases in All Patients With Hypertension That Are Treated in Primary Care in Stockholm, Sweden.J Clin Hypertens (Greenwich). 2025 Jan;27(1):e14940. doi: 10.1111/jch.14940. Epub 2024 Nov 16. J Clin Hypertens (Greenwich). 2025. PMID: 39549243 Free PMC article.
References
-
- Centers for Disease Control and Prevention. LCWK9. Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and each state, 2013. 2014. http://www.cdc.gov/nchs/data/dvs/LCWK9_2013.pdf. Accessed February 3, 2016.
-
- Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458-2473. - PubMed
-
- Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121:750-758. - PubMed
-
- Teo K, Lear S, Islam S, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013;309:1613-1621. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources